Patents by Inventor Heino Eikmeier
Heino Eikmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11221324Abstract: Disclosed herein are portable diagnostic measurement devices for determining at least one analysis parameter of a bodily fluid, in particular for determining an analyte concentration in a bodily fluid as can occur in blood glucose determinations. Also disclosed are analysis systems including the measurement device and at least one disposable test element. The test element can be designed as a carrier strip and can contact a receiving surface of the measurement device at least partially in a flat manner, where the receiving surface is arranged on a narrow side of the housing of the measurement device.Type: GrantFiled: October 15, 2018Date of Patent: January 11, 2022Assignee: Roche Diabetes Care, Inc.Inventors: Heino Eikmeier, Hans-Peter Haar, Joachim Hoenes, Carina Horn, Ewald Rieger
-
Patent number: 10368745Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.Type: GrantFiled: February 2, 2018Date of Patent: August 6, 2019Assignee: ROCHE DIABETES CARE INCInventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
-
Publication number: 20190049427Abstract: Disclosed herein are portable diagnostic measurement devices for determining at least one analysis parameter of a bodily fluid, in particular for determining an analyte concentration in a bodily fluid as can occur in blood glucose determinations. Also disclosed are analysis systems including the measurement device and at least one disposable test element. The test element can be designed as a carrier strip and can contact a receiving surface of the measurement device at least partially in a flat manner, where the receiving surface is arranged on a narrow side of the housing of the measurement device.Type: ApplicationFiled: October 15, 2018Publication date: February 14, 2019Inventors: Heino Eikmeier, Hans-Peter Haar, Joachim Hoenes, Carina Horn, Ewald Rieger
-
Patent number: 10132792Abstract: Disclosed herein are portable diagnostic measurement devices for determining at least one analysis parameter of a bodily fluid, in particular for determining an analyte concentration in a bodily fluid as can occur in blood glucose determinations. Also disclosed are analysis systems including the measurement device and at least one disposable test element. The test element can be designed as a carrier strip and can contact a receiving surface of the measurement device at least partially in a flat manner, where the receiving surface is arranged on a narrow side of the housing of the measurement device.Type: GrantFiled: September 27, 2013Date of Patent: November 20, 2018Assignee: Roche Diabetes Care, Inc.Inventors: Heino Eikmeier, Hans-Peter Haar, Joachim Hoenes, Carina Horn, Ewald Rieger
-
Publication number: 20180168448Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.Type: ApplicationFiled: February 2, 2018Publication date: June 21, 2018Applicant: Roche Diabetes Care, Inc.Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, Ajay Thukral, Heino Eikmeier, Birgit Kraeling, Karl Warner, Ulrich Porsch
-
Patent number: 9918635Abstract: Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.Type: GrantFiled: June 18, 2010Date of Patent: March 20, 2018Assignee: Roche Diabetes Care, Inc.Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
-
Publication number: 20170059506Abstract: Storage containers are disclosed for storing at least one diagnostic test element including an enzyme and a stabilized coenzyme. In addition, diagnostic products such as test elements are disclosed that include an enzyme and a stabilized coenzyme, as well as analytical measuring devices including such storage containers and/or diagnostic products. Other aspects include, but are not limited to, unique methods, techniques, products, systems and devices involving test elements, such as test strips, including the enzyme and the stabilized coenzyme.Type: ApplicationFiled: November 16, 2016Publication date: March 2, 2017Inventors: Carina Horn, Christian Freitag, Hans-Peter Haar, Heino Eikmeier
-
Patent number: 9528977Abstract: Storage containers for storing at least one diagnostic test element including an enzyme and a stabilized coenzyme are disclosed. In addition, diagnostic products which include diagnostic test elements including an enzyme and a stabilized coenzyme, as well as analytical measuring devices which include such storage containers or diagnostic products, are also disclosed. Other aspects include, but are not limited to, unique methods, techniques, products, systems and devices involving test elements which include an enzyme and a stabilized coenzyme.Type: GrantFiled: February 20, 2012Date of Patent: December 27, 2016Assignee: ROCHE DIABETES CARE, INC.Inventors: Carina Horn, Christian Freitag, Hans-Peter Haar, Heino Eikmeier
-
Publication number: 20140238118Abstract: Disclosed herein are portable diagnostic measurement devices for determining at least one analysis parameter of a bodily fluid, in particular for determining an analyte concentration in a bodily fluid as can occur in blood glucose determinations. Also disclosed are analysis systems including the measurement device and at least one disposable test element. The test element can be designed as a carrier strip and can contact a receiving surface of the measurement device at least partially in a flat manner, where the receiving surface is arranged on a narrow side of the housing of the measurement device.Type: ApplicationFiled: September 27, 2013Publication date: August 28, 2014Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Heino Eikmeier, Hans-Peter Haar, Joachim Hoenes, Carina Horn, Ewald Rieger
-
Publication number: 20140041443Abstract: Disclosed herein are portable diagnostic measurement devices for determining at least one analysis parameter of a bodily fluid, in particular for determining an analyte concentration in a bodily fluid as can occur in blood glucose determinations. Also disclosed are analysis systems including the measurement device and at least one disposable test element. The test element can be designed as a carrier strip and can contact a receiving surface of the measurement device at least partially in a flat manner, where the receiving surface is arranged on a narrow side of the housing of the measurement device.Type: ApplicationFiled: September 27, 2013Publication date: February 13, 2014Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Heino Eikmeier, Hans-Peter Haar, Joachim Hoenes, Carina Horn, Ewald Rieger
-
Patent number: 8628721Abstract: A system is provided for measuring an analyte concentration in a body fluid sample, comprising at least one cartridge that contains consumables for multiple measurements, a data carrier affixed to the cartridge that contains calibration information for the consumables, a hand-held device including a reading facility for receiving a cartridge of this type and for reading its data carrier, a measuring facility for measuring the result of a detection reaction, and a processor for controlling the measuring facility and for analysis of a measuring signal. At least one replaceable data storage unit is further provided in which supplementary data is stored. The data storage unit functions in combination with calibration information from the data carrier and is used by the processor to determine whether the consumables of the inserted cartridge renders a reliable measurement of analyte concentration.Type: GrantFiled: December 15, 2009Date of Patent: January 14, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Christoph Eisenhardt, Heino Eikmeier
-
Publication number: 20120241335Abstract: Storage containers for storing at least one diagnostic test element including an enzyme and a stabilized coenzyme are disclosed. In addition, diagnostic products which include diagnostic test elements including an enzyme and a stabilized coenzyme, as well as analytical measuring devices which include such storage containers or diagnostic products, are also disclosed. Other aspects include, but are not limited to, unique methods, techniques, products, systems and devices involving test elements which include an enzyme and a stabilized coenzyme.Type: ApplicationFiled: February 20, 2012Publication date: September 27, 2012Inventors: Carina Horn, Christian Freitag, Hans-Peter Haar, Heino Eikmeier
-
Publication number: 20110015511Abstract: Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.Type: ApplicationFiled: June 18, 2010Publication date: January 20, 2011Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
-
Patent number: 7749441Abstract: An automatic analyzer is disclosed that dispenses a sample and a reagent into each of a plurality of reaction vessels to allow them to react with each other, and that measures the liquid formed as a result of the reaction. This automatic analyzer includes a first reagent storage case for storing the reagent to be used for the reaction, a second reagent storage case for storing the reagent for supplemental purpose, and a reagent conveying unit for conveying the reagent from the second reagent storage case to the first reagent storage case.Type: GrantFiled: July 15, 2004Date of Patent: July 6, 2010Assignees: Hitachi High-Technologies Corporation, Roche Diagnostics Operations, Inc.Inventors: Masaaki Hanawa, Isao Yamazaki, Hitoshi Tokieda, Masaharu Nishida, Masaki Shiba, Heino Eikmeier, Dietmar Kappelhoff, Christoph Möllers, Stephan Sattler
-
Publication number: 20100119414Abstract: A system is provided for measuring an analyte concentration in a body fluid sample, comprising at least one cartridge that contains consumables for multiple measurements, a data carrier which is affixed to the cartridge and contains calibration information for the consumables contained in the cartridge, a hand-held device that comprises a cartridge reception compartment including a reading facility for receiving a cartridge of this type and for reading its data carrier, a measuring facility for measuring the result of a detection reaction, a processor that is connected to the measuring facility and the reading facility for controlling the measuring facility and for analysis of a measuring signal. As an additional system component, at least one replaceable data storage unit is further provided in which supplementary data is stored.Type: ApplicationFiled: December 15, 2009Publication date: May 13, 2010Inventors: Christoph Eisenhardt, Heino Eikmeier
-
Publication number: 20050207938Abstract: An automatic analyzer is disclosed that dispenses a sample and a reagent into each of a plurality of reaction vessels to allow them to react with each other, and that measures the liquid formed as a result of the reaction. This automatic analyzer includes a first reagent storage case for storing the reagent to be used for the reaction, a second reagent storage case for storing the reagent for supplemental purpose, and a reagent conveying unit for conveying the reagent from the second reagent storage case to the first reagent storage case.Type: ApplicationFiled: July 15, 2004Publication date: September 22, 2005Inventors: Masaaki Hanawa, Isao Yamazaki, Hitoshi Tokieda, Masaharu Nishida, Masaki Shiba, Heino Eikmeier, Dietmar Kappelhoff, Christoph Mollers, Stephan Sattler
-
Patent number: 5863800Abstract: A systems for test elements used for clinical chemical analyses has several test elements, each of which is individually sealed to be impermeable to water vapor. The method provides for the removal of test elements and protects the test elements contained in it against effects from the outside.Type: GrantFiled: September 22, 1997Date of Patent: January 26, 1999Assignee: Boehringer Mannheim GmbHInventors: Heino Eikmeier, Klaus-Dieter Sacherer, Joerg Schreiber, Wilfried Schmid, Hans-Juergen Kuhr
-
Patent number: 5720924Abstract: The system has several test elements, each of which is individually sealed to be impermeable to water vapor. The system storing test elements facilitates removal of test elements and protects the test elements contained in it against effects from the outside.Type: GrantFiled: March 1, 1996Date of Patent: February 24, 1998Assignee: Boehringer Mannheim GmbHInventors: Heino Eikmeier, Klaus-Dieter Sacherer, Joerg Schreiber, Wilfried Schmid, Hans-Juergen Kuhr
-
Patent number: 5645798Abstract: A system for analyzing sample liquids using dry reagents which is particularly suitable for the determination of clinical parameters. The system includes an analysis instrument containing the individually sealed test elements to carry out an analytical test. Shape and nature of the test elements were designed to match the analysis system. The system is particularly suitable for analyses where the available test elements exhibit a low storage stability when brought into contact with the environment.Type: GrantFiled: June 5, 1995Date of Patent: July 8, 1997Assignee: Boehringer Mannheim GmbHInventors: Joerg Schreiber, Wilfried Schmid, Hans-Juergen Kuhr, Heino Eikmeier, Klaus-Dieter Sacherer
-
Patent number: 5505308Abstract: The invention is within the field of packaging and storing of test elements that are usually sensitive towards atmospheric humidity or water vapor. The invention concerns a system for the storage of test elements for the analysis of sample liquids in which two or more test elements are present in a storage container which can be sealed water-vapor tight and contains a desiccant inside.Type: GrantFiled: August 25, 1994Date of Patent: April 9, 1996Assignee: Boehringer Mannheim GmbHInventors: Heino Eikmeier, Klaus-Dieter Sacherer